Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT)

PHASE2WithdrawnINTERVENTIONAL

Timeline

Start Date

May 31, 2020

Primary Completion Date

May 31, 2020

Study Completion Date

December 31, 2021

Conditions

Autism Spectrum DisorderAutismASDAutistic ThinkingAutistic BehaviorFinchFMTFecal Microbiota TransplantCP101SPROUTFecal Transplant

Interventions

DRUG

CP101

Orally administered donor derived full spectrum microbiota

DRUG

Placebo

Placebo for CP101